211 related articles for article (PubMed ID: 24955551)
21. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.
Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Zarate CA
Bipolar Disord; 2015 Jun; 17(4):438-43. PubMed ID: 25400146
[TBL] [Abstract][Full Text] [Related]
22. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
DiazGranados N; Ibrahim LA; Brutsche NE; Ameli R; Henter ID; Luckenbaugh DA; Machado-Vieira R; Zarate CA
J Clin Psychiatry; 2010 Dec; 71(12):1605-11. PubMed ID: 20673547
[TBL] [Abstract][Full Text] [Related]
23. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
[TBL] [Abstract][Full Text] [Related]
24. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine.
Papakostas GI; Petersen T; Lebowitz BD; Mischoulon D; Ryan JL; Nierenberg AA; Bottiglieri T; Alpert JE; Rosenbaum JF; Fava M
Int J Neuropsychopharmacol; 2005 Dec; 8(4):523-8. PubMed ID: 15877935
[TBL] [Abstract][Full Text] [Related]
25. Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.
Rong C; Park C; Rosenblat JD; Subramaniapillai M; Zuckerman H; Fus D; Lee YL; Pan Z; Brietzke E; Mansur RB; Cha DS; Lui LMW; McIntyre RS
Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29673146
[TBL] [Abstract][Full Text] [Related]
26. Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.
Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539512
[TBL] [Abstract][Full Text] [Related]
27. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression.
Ibrahim L; Diazgranados N; Luckenbaugh DA; Machado-Vieira R; Baumann J; Mallinger AG; Zarate CA
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1155-9. PubMed ID: 21466832
[TBL] [Abstract][Full Text] [Related]
28. Ketamine augmentation rapidly improves depression scores in inpatients with treatment-resistant bipolar depression.
Rybakowski JK; Permoda-Osip A; Bartkowska-Sniatkowska A
Int J Psychiatry Clin Pract; 2017 Jun; 21(2):99-103. PubMed ID: 28271731
[TBL] [Abstract][Full Text] [Related]
29. Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.
Xu AJ; Niciu MJ; Lundin NB; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Machado-Vieira R; Zarate CA
Neural Plast; 2015; 2015():858251. PubMed ID: 26137324
[TBL] [Abstract][Full Text] [Related]
30. Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder.
Vande Voort JL; Ballard ED; Luckenbaugh DA; Bernert RA; Richards EM; Niciu MJ; Park LT; Machado-Vieira R; Duncan WC; Zarate CA
J Clin Psychiatry; 2017; 78(8):1068-1074. PubMed ID: 27929610
[TBL] [Abstract][Full Text] [Related]
31. Intravenous ketamine therapy in a patient with a treatment-resistant major depression.
Liebrenz M; Borgeat A; Leisinger R; Stohler R
Swiss Med Wkly; 2007 Apr; 137(15-16):234-6. PubMed ID: 17525879
[TBL] [Abstract][Full Text] [Related]
32. Characterizing the course of suicidal ideation response to ketamine.
Ballard ED; Yarrington JS; Farmer CA; Richards E; Machado-Vieira R; Kadriu B; Niciu MJ; Yuan P; Park L; Zarate CA
J Affect Disord; 2018 Dec; 241():86-93. PubMed ID: 30099268
[TBL] [Abstract][Full Text] [Related]
33. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
J Psychiatr Res; 2018 Nov; 106():61-68. PubMed ID: 30278319
[TBL] [Abstract][Full Text] [Related]
34. Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist.
Phelps LE; Brutsche N; Moral JR; Luckenbaugh DA; Manji HK; Zarate CA
Biol Psychiatry; 2009 Jan; 65(2):181-4. PubMed ID: 18996507
[TBL] [Abstract][Full Text] [Related]
35. An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression.
Salvadore G; van der Veen JW; Zhang Y; Marenco S; Machado-Vieira R; Baumann J; Ibrahim LA; Luckenbaugh DA; Shen J; Drevets WC; Zarate CA
Int J Neuropsychopharmacol; 2012 Sep; 15(8):1063-72. PubMed ID: 22040773
[TBL] [Abstract][Full Text] [Related]
36. Sustained antidepressant response to ketamine.
Atigari OV; Healy D
BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23960151
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.
Zarate CA; Mathews D; Ibrahim L; Chaves JF; Marquardt C; Ukoh I; Jolkovsky L; Brutsche NE; Smith MA; Luckenbaugh DA
Biol Psychiatry; 2013 Aug; 74(4):257-64. PubMed ID: 23206319
[TBL] [Abstract][Full Text] [Related]
38. The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.
Niciu MJ; Iadarola ND; Banerjee D; Luckenbaugh DA; Park M; Lener M; Park L; Ionescu DF; Ballard ED; Brutsche NE; Akula N; McMahon FJ; Machado-Vieira R; Nugent AC; Zarate CA
J Psychopharmacol; 2017 Dec; 31(12):1570-1577. PubMed ID: 29039254
[TBL] [Abstract][Full Text] [Related]
39. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
Murrough JW; Iosifescu DV; Chang LC; Al Jurdi RK; Green CE; Perez AM; Iqbal S; Pillemer S; Foulkes A; Shah A; Charney DS; Mathew SJ
Am J Psychiatry; 2013 Oct; 170(10):1134-42. PubMed ID: 23982301
[TBL] [Abstract][Full Text] [Related]
40. The use of ketamine as an antidepressant: a systematic review and meta-analysis.
Coyle CM; Laws KR
Hum Psychopharmacol; 2015 May; 30(3):152-63. PubMed ID: 25847818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
